These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 27653301

  • 1. Clinical Outcome of Patients With De Novo C1q-Binding Donor-Specific HLA Antibodies After Renal Transplantation.
    Bamoulid J, Roodenburg A, Staeck O, Wu K, Rudolph B, Brakemeier S, Halleck F, Lehner L, Schönemann C, Lachmann N, Budde K.
    Transplantation; 2017 Sep; 101(9):2165-2174. PubMed ID: 27653301
    [Abstract] [Full Text] [Related]

  • 2. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
    Lee H, Han E, Choi AR, Ban TH, Chung BH, Yang CW, Choi YJ, Oh EJ.
    PLoS One; 2018 Sep; 13(11):e0207434. PubMed ID: 30427941
    [Abstract] [Full Text] [Related]

  • 3. C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.
    Yell M, Muth BL, Kaufman DB, Djamali A, Ellis TM.
    Transplantation; 2015 Jun; 99(6):1151-5. PubMed ID: 25839705
    [Abstract] [Full Text] [Related]

  • 4. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
    Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
    [Abstract] [Full Text] [Related]

  • 5. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
    Malheiro J, Santos S, Tafulo S, Dias L, Martins S, Fonseca I, Almeida M, Pedroso S, Beirão I, Castro-Henriques A, Cabrita A.
    Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.
    Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, Kikić Ž, Haslacher H, Rasoul-Rockenschaub S, Kaltenecker CC, König F, Hidalgo LG, Oberbauer R, Halloran PF, Böhmig GA.
    Transplantation; 2017 Mar; 101(3):631-641. PubMed ID: 27120452
    [Abstract] [Full Text] [Related]

  • 7. Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy.
    Messina M, Ariaudo C, Praticò Barbato L, Beltramo S, Mazzucco G, Amoroso A, Ranghino A, Cantaluppi V, Fop F, Segoloni GP, Biancone L.
    Transpl Immunol; 2015 Sep; 33(1):7-12. PubMed ID: 26160049
    [Abstract] [Full Text] [Related]

  • 8. Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d⁺ Antibody-Mediated Rejection in Kidney Transplant Recipients.
    Tatapudi VS, Kopchaliiska D, da Gente GJ, Buenaventura OF, Singh M, Laszik Z, Adey DB, Rajalingam R.
    Ann Transplant; 2021 Dec 01; 26():e934175. PubMed ID: 34848674
    [Abstract] [Full Text] [Related]

  • 9. De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.
    Cioni M, Nocera A, Innocente A, Tagliamacco A, Trivelli A, Basso S, Quartuccio G, Fontana I, Magnasco A, Drago F, Gurrado A, Guido I, Compagno F, Garibotto G, Klersy C, Verrina E, Ghiggeri GM, Cardillo M, Comoli P, Ginevri F.
    J Immunol Res; 2017 Dec 01; 2017():1747030. PubMed ID: 28367453
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Post-transplant development of C1q-positive HLA antibodies and kidney graft survival.
    Piazza A, Poggi E, Ozzella G, Adorno D.
    Clin Transpl; 2013 Dec 01; ():367-75. PubMed ID: 25095531
    [Abstract] [Full Text] [Related]

  • 18. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation.
    Okabe Y, Noguchi H, Miyamoto K, Kaku K, Tsuchimoto A, Masutani K, Nakamura M.
    Transplant Proc; 2018 Dec 01; 50(10):3460-3466. PubMed ID: 30577221
    [Abstract] [Full Text] [Related]

  • 19. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.
    Freitas MC, Rebellato LM, Ozawa M, Nguyen A, Sasaki N, Everly M, Briley KP, Haisch CE, Bolin P, Parker K, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI.
    Transplantation; 2013 May 15; 95(9):1113-9. PubMed ID: 23514959
    [Abstract] [Full Text] [Related]

  • 20. Acquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney Recipients.
    Comoli P, Cioni M, Tagliamacco A, Quartuccio G, Innocente A, Fontana I, Trivelli A, Magnasco A, Nocco A, Klersy C, Rubert L, Ramondetta M, Zecca M, Garibotto G, Ghiggeri GM, Cardillo M, Nocera A, Ginevri F.
    Am J Transplant; 2016 Jul 15; 16(7):2106-16. PubMed ID: 26725780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.